Halozyme Therapeutics
HALO
#2189
Rank
โ‚น603.43 B
Marketcap
โ‚น4,743
Share price
-1.03%
Change (1 day)
58.22%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น23.89 M-6.29%
2023โ‚น25.5 M-15.59%
2022โ‚น30.2 M38.39%
2021โ‚น21.82 M-6.23%
2020โ‚น23.27 M-44.23%
2019โ‚น41.74 M591.9%
2018โ‚น6.03 M-64.48%
2017โ‚น16.98 M-5.65%
2016โ‚น17.99 M-13.05%
2015โ‚น20.7 M-7.81%
2014โ‚น22.45 M140.61%
2013โ‚น9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น0.14 Mโ‚น13.31 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น74.57 Mโ‚น0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.76 Mโ‚น38.81 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น37.96 Mโ‚น0.35 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.14 Mโ‚น72.79 M๐Ÿ‡ซ๐Ÿ‡ท France
โ‚น22.46 Mโ‚น0.33 B๐Ÿ‡บ๐Ÿ‡ธ USA